Pharmacology, Toxicology and Pharmaceutical Science
Lipoprotein
100%
Diabetes Mellitus
37%
Triacylglycerol
31%
Saturated Fatty Acid
29%
Flutamide
24%
Non Insulin Dependent Diabetes Mellitus
24%
Dyslipidemia
22%
Androgen
22%
Metabolic Disorder
22%
High Density Lipoprotein Cholesterol
22%
High Density Lipoprotein
20%
Low Density Lipoprotein
20%
Insulin Dependent Diabetes Mellitus
18%
Pistachio
18%
Pioglitazone
18%
Nonessential Amino Acid
18%
Fenofibrate
18%
Simvastatin
18%
Laropiprant Plus Nicotinic Acid
18%
Omega-3 Fatty Acid
18%
Fluorescent Dye
18%
Combination Therapy
18%
Normal Human
18%
Atomic Force Microscopy
18%
Metformin
18%
Ovary Polycystic Disease
18%
Pharmacotherapy
18%
Cholesterol Ester
18%
Cardiovascular Disease
13%
Disease
13%
Apolipoprotein A1
12%
Methionine
12%
Glutamic Acid
12%
Impaired Glucose Tolerance
10%
Low Density Lipoprotein Cholesterol
8%
Progestin
7%
Azelaic Acid
7%
Very Low Density Lipoprotein
6%
Hypertriglyceridemia
6%
Health Hazard
6%
Metformin Plus Pioglitazone
6%
Hyperglycemia
6%
Methionine Sulfoxide
6%
Metabolic Syndrome X
6%
Inflammation
6%
Biochemistry, Genetics and Molecular Biology
Lipoprotein
83%
Dyslipidemia
56%
Metabolite
49%
Metabolomics
43%
Lipid
37%
Magnetism
28%
Facilitated Diffusion
23%
Metabolic Disorder
23%
Pioglitazone
18%
Metabolomics
18%
Data Analysis
18%
Software
18%
Fatty Acid-Binding Protein
18%
Omega 3 Fatty Acid
18%
Amino Acids
18%
Genetic Association
18%
Age
18%
Normal Human
18%
Serum (Blood)
18%
Metabolome
18%
Lipoprotein Blood Level
18%
PCSK9
18%
Low-Density Lipoprotein
18%
Saturated Fat
18%
Blood Plasma
14%
Polyunsaturated Fatty Acid
13%
Blood Level
12%
Low Drug Dose
12%
Molecular Weight
12%
Glutamic Acid
12%
Methionine
12%
Genetic Divergence
11%
HDL-Cholesterol
10%
Principal Component Analysis
10%
Insulin Resistance
7%
Single Nucleotide Polymorphism
7%
Diffusion Coefficient
7%
Lipid Profile
7%
Saturated Fatty Acids
6%
Lipid Metabolism
5%
Glucose Metabolism
5%
Genome-Wide Association Study
5%
Genetics
5%
Medicine and Dentistry
NMR Spectroscopy
47%
Metabolomics
37%
Lipoprotein
22%
Diseases
22%
Dyslipidemia
22%
Flutamide
18%
Public Health
18%
Horn
18%
Protein Z
18%
Nutritional Intervention
18%
Glycon
18%
Polycystic Ovary Syndrome
18%
Pioglitazone
18%
Combination Therapy
18%
Analysis
18%
Plantago ovata
18%
Pollutant
18%
Psychoacoustics
18%
Proton Nuclear Magnetic Resonance
18%
Volunteer
18%
Obesity
11%
Triacylglycerol
10%
Low Drug Dose
7%
Biological Marker
7%
Intima-Media Thickness
7%
Gestagen
7%
Azelaic Acid
7%
Single Nucleotide Polymorphism
7%
Atherosclerosis
7%
Human Study
7%
Cardiovascular Disease
6%